Health ❯Healthcare ❯Immunology

Antibody Response

Neutralizing Antibodies Immunoglobulin G (IgG) Delta and Omicron Infections Vaccine Efficacy High-Risk Populations Vaccine Immunogenicity

FDA Expands Moderna RSV Vaccine to Adults 18–59 at Risk

CDC endorsement is required before the shots reach this group following contested advisory panel appointments

Trans-amplifying mRNA vaccine delivers broad SARS-CoV-2 variant protection with 40-fold lower dosage

Original COVID-19 Vaccine Sustains Broad Protection Against Delta and Omicron

Moderna’s Combined COVID-19 and Flu Vaccine Shows Promising Phase III Results

FDA Halts Novavax's COVID-Flu Combo Vaccine Trial Over Safety Concerns